<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> dysfunction and <z:mp ids='MP_0003674'>oxidative stress</z:mp> in insulin responsive tissues is implicated in the pathogenesis of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Whether these perturbations extend to other tissues and contribute to their pathophysiology is less well established </plain></SENT>
<SENT sid="2" pm="."><plain>The objective of this study was to investigate platelet mitochondria to evaluate whether type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> associated <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction is evident in circulating cells </plain></SENT>
<SENT sid="3" pm="."><plain>METHOD: A pilot study of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> respiratory function and proteomic changes comparing platelets extracted from insulin sensitive (n=8) and type 2 diabetic subjects (n=7) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: In-situ platelet mitochondria show diminished oxygen consumption and lower oxygen-dependent ATP synthesis in diabetic vs. control subjects </plain></SENT>
<SENT sid="5" pm="."><plain>Mass spectrometric identification and confirmatory immunoblot analysis identifies induction of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> anti-oxidant enzymes <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase 2 and <z:chebi fb="0" ids="15033">thioredoxin</z:chebi>-dependent <z:chebi fb="39" ids="44785">peroxide</z:chebi> reductase 3 in platelets of diabetic subjects </plain></SENT>
<SENT sid="6" pm="."><plain>As <z:mp ids='MP_0003674'>oxidative stress</z:mp> upregulates anti-oxidant enzymes we assessed <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> protein carbonylation as an index of <z:mp ids='MP_0003674'>oxidative-stress</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Platelets of diabetic subjects exhibit significantly increased protein carbonylation compared to controls </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: As platelets are anuclear fragments of megakaryocytes, our data suggest that the bone marrow compartment in type 2 diabetic subjects is exposed to increased <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:mp ids='MP_0003674'>oxidative stress</z:mp> with upregulation of nuclear-encoded <z:chebi fb="11" ids="22586">antioxidant</z:chebi> <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> enzymes </plain></SENT>
<SENT sid="9" pm="."><plain>This 'stress-signature' in platelets of diabetic subjects is associated with a diminution of their <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> contribution to energy production and support that <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> perturbations in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> extends beyond the classical insulin responsive tissues </plain></SENT>
<SENT sid="10" pm="."><plain>Platelets, as "accessible human tissue", may be useful to measure the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> modulatory effects of emerging anti-diabetic therapeutics </plain></SENT>
</text></document>